Resultados de procura - Murphy, Sabina
- Mostrando 1 - 20 Resultados de 48
- Go to Next Page
-
1
Efficacy and Safety of Further Lowering of Low-Density Lipoprotein Cholesterol in Patients Starting With Very Low Levels: A Meta-analysis por Sabatine, Marc S., Wiviott, Stephen D., Im, KyungAh, Murphy, Sabina A., Giugliano, Robert P.
Publicado 2018Text -
2
-
3
-
4
Central obesity and cardiovascular outcomes in patients with acute coronary syndrome: observations from the MERLIN-TIMI 36 trial por Kadakia, Mitul B, Fox, Caroline S, Scirica, Benjamin M, Murphy, Sabina A, Bonaca, Marc P, Morrow, David A
Publicado 2011Text -
5
Influence of Race and Sex on Lipoprotein-Associated Phospholipase A2 Levels: Observations from the Dallas Heart Study por Brilakis, Emmanouil S., Khera, Amit, McGuire, Darren K., See, Raphael, Banerjee, Subhash, Murphy, Sabina A., de Lemos, James A.
Publicado 2007Text -
6
Assessment of multiple cardiac biomarkers in non-ST-segment elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 Trial por Scirica, Benjamin M., Sabatine, Marc S., Jarolim, Petr, Murphy, Sabina A., de Lemos, James L., Braunwald, Eugene, Morrow, David A.
Publicado 2011Text -
7
Evaluation of the diagnostic performance of current and next-generation assays for cardiac troponin I in the BWH-TIMI ED Chest Pain Study por Bonaca, Marc P, Ruff, Christian T, Kosowsky, Joshua, Conrad, Michael J, Murphy, Sabina A, Sabatine, Marc S, Jarolim, Petr, Morrow, David A
Publicado 2013Text -
8
Diagnostic Performance of Copeptin in Patients With Acute Nontraumatic Chest Pain: BWH‐TIMI ED Chest Pain Study por Sukul, Devraj, Bonaca, Marc P., Ruff, Christian T., Kosowsky, Joshua, Conrad, Michael, Murphy, Sabina A., Sabatine, Marc S., Jarolim, Petr, Morrow, David A.
Publicado 2014Text -
9
Diagnostic evaluation of the MRP-8/14 for the emergency assessment of chest pain por Vora, Amit N., Bonaca, Marc P., Ruff, Christian T., Jarolim, Petr, Murphy, Sabina, Croce, Kevin, Sabatine, Marc S., Simon, Daniel I., Morrow, David A.
Publicado 2012Text -
10
The prognostic significance of cardiac structure and function in atrial fibrillation: the ENGAGE AF-TIMI 48 Echocardiographic Substudy por Gupta, Deepak K, Giugliano, Robert P, Ruff, Christian T, Claggett, Brian, Murphy, Sabina, Antman, Elliott, Mercuri, Michele F., Braunwald, Eugene, Solomon, Scott D
Publicado 2016Text -
11
Prognostic Evaluation of Catalytic Iron in Patients With Acute Coronary Syndromes por Steen, Dylan L., Cannon, Christopher P., Lele, Suhas S., Rajapurkar, Mohan M., Mukhopadhyay, Banibrata, Scirica, Benjamin M., Murphy, Sabina A., Morrow, David A.
Publicado 2013Text -
12
Effects of Ranolazine in Patients With Chronic Angina in Patients With and Without Percutaneous Coronary Intervention for Acute Coronary Syndrome: Observations From the MERLIN‐TIMI... por Gutierrez, Jorge A., Karwatowska‐Prokopczuk, Ewa, Murphy, Sabina A., Belardinelli, Luiz, Farzaneh‐Far, Ramin, Walker, Gennyne, Morrow, David A., Scirica, Benjamin M.
Publicado 2015Text -
13
Concomitant Use of Single Antiplatelet Therapy With Edoxaban or Warfarin in Patients With Atrial Fibrillation: Analysis From the ENGAGE AF‐TIMI48 Trial por Xu, Haiyan, Ruff, Christian T., Giugliano, Robert P., Murphy, Sabina A., Nordio, Francesco, Patel, Indravadan, Shi, Minggao, Mercuri, Michele, Antman, Elliott M., Braunwald, Eugene
Publicado 2016Text -
14
Cystatin C for Risk Stratification in Patients After an Acute Coronary Syndrome por Correa, Simon, Morrow, David A., Braunwald, Eugene, Davies, Richard Y., Goodrich, Erica L., Murphy, Sabina A., Cannon, Christopher P., O'Donoghue, Michelle L.
Publicado 2018Text -
15
Reduction in recurrent cardiovascular events with prasugrel compared with clopidogrel in patients with acute coronary syndromes from the TRITON-TIMI 38 trial por Murphy, Sabina A., Antman, Elliott M., Wiviott, Stephen D., Weerakkody, Govinda, Morocutti, Giorgio, Huber, Kurt, Lopez-Sendon, Jose, McCabe, Carolyn H., Braunwald, Eugene
Publicado 2008Text -
16
Evaluation of coronary artery calcium screening strategies focused on risk categories: The Dallas Heart Study por Patel, Mahesh J., de Lemos, James A., McGuire, Darren K., See, Raphael, Lindsey, Jason B., Murphy, Sabina A., Grundy, Scott M., Khera, Amit
Publicado 2009Text -
17
Osteoprotegerin and cardiovascular mortality in patients with non-ST elevation acute coronary syndromes por Røysland, Ragnhild, Bonaca, Marc P, Omland, Torbjørn, Sabatine, Marc, Murphy, Sabina A, Scirica, Benjamin M, Bjerre, Mette, Flyvbjerg, Allan, Braunwald, Eugene, Morrow, David A
Publicado 2012Text -
18
Clinical Features, Use of Evidence‐Based Therapies, and Cardiovascular Outcomes Among Patients With Chronic Kidney Disease Following Non–ST‐Elevation Acute Coronary Syndrome por Rhee, June‐Wha, Wiviott, Stephen D., Scirica, Benjamin M., Gibson, C. Michael, Murphy, Sabina A., Bonaca, Marc P., Morrow, David A., Mega, Jessica L.
Publicado 2014Text -
19
Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18 por Morrow, David A., Sabatine, Marc S., Brennan, Marie-Luise, de Lemos, James A., Murphy, Sabina A., Ruff, Christian T., Rifai, Nader, Cannon, Christopher P., Hazen, Stanley L.
Publicado 2008Text -
20
Role of ST2 in Non–ST-Elevation Acute Coronary Syndrome in the MERLIN-TIMI 36 Trial por Kohli, Payal, Bonaca, Marc P., Kakkar, Rahul, Kudinova, Anastacia Y., Scirica, Benjamin M., Sabatine, Marc S., Murphy, Sabina A., Braunwald, Eugene, Lee, Richard T., Morrow, David A.
Publicado 2011Text